Comparative study of the inhibitory effects of different antibiotic administration routes on bone healing in a rat tibial infection model
Open Access
- 28 February 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1529692
Abstract
Objective: This study aimed to evaluate the effectiveness of intravenous versus oral antibiotic treatments in managing bone infections, particularly osteomyelitis, using a rat tibial infection model.Methods: A tibial bone infection model was established in twelve-week-old Wistar rats via injection of Staphylococcus aureus at a cortical defect site. After six weeks, rats were treated with vancomycin (intravenous), cefazolin (intravenous), ciprofloxacin (oral), or ciprofloxacin combined with rifampin (oral). Microbial analysis, blood analysis for pro-inflammatory cytokines, micro-computed tomography (μCT), histological analysis, and osteoclast activity were used to assess the efficacy of each treatment.Results: Blood analysis showed significant reductions in white blood cell count and pro-inflammatory cytokines in the intravenous treatment groups, especially with vancomycin. μCT imaging revealed better preservation of bone structure in intravenous treatment groups, while oral treatments resulted in more pronounced structural deterioration. Microbial analysis confirmed a lower bacterial load in the intravenous groups, particularly vancomycin, compared to oral treatments. Histological analysis revealed reduced inflammation, lower fibrosis, and minimal bacterial presence in intravenous groups. Osteoclast activity was notably reduced in the vancomycin and cefazolin groups, indicating better control of bone resorption.Conclusion: Intravenous administration of vancomycin demonstrated superior efficacy in controlling bone infection, reducing inflammation, and preserving bone structure compared to oral treatments. While ciprofloxacin and the ciprofloxacin-rifampin combination showed some efficacy, they were less effective than intravenous vancomycin, likely due to lower bioavailability and insufficient drug penetration in bone tissue.Keywords
This publication has 20 references indexed in Scilit:
- Early switch from intravenous to oral antibiotic treatment in bone and joint infectionsClinical Microbiology and Infection, 2023
- Role of Lysine‐Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia‐Inducible Factor 1α and E2F1Arthritis & Rheumatology, 2022
- Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in OsteomyelitisCurrent Osteoporosis Reports, 2019
- Antibiotic penetration into bone and joints: An updated reviewInternational Journal of Infectious Diseases, 2019
- Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitisJournal of Infection, 2015
- Local gentamicin application does not interfere with bone healing in a rat modelBone, 2013
- OsteomyelitisThe Lancet, 2004
- Systematic review and meta-analysis of antibiotic therapy for bone and joint infectionsThe Lancet Infectious Diseases, 2001
- Role of Rifampin for Treatment of Orthopedic Implant–Related Staphylococcal Infections A Randomized Controlled TrialJAMA, 1998
- Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibioticsThe American Journal of Medicine, 1991